Mgo One Seven LLC Halozyme Therapeutics, Inc. Transaction History

Mgo One Seven LLC

$2.26 Billion
Q3 2024

A detailed history of Mgo One Seven LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mgo One Seven LLC holds 5,394 shares of HALO stock, worth $253,302. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,394

Previous 10,690 49.54%

Holding current value

$253,302

Previous $559,000 44.9%

% of portfolio

0.01%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$51.3 - $64.42 $271,684 - $341,168	-5,296 Reduced 49.54%	5,394 $308,000
Q2 2024 Aug 07, 2024	SELL	$37.81 - $52.4 $7,221 - $10,008	-191 Reduced 1.76%	10,690 $559,000
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $5,826 - $7,257	173 Added 1.62%	10,881 $442,000
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $38,751 - $48,962	-1,163 Reduced 9.8%	10,708 $395,000
Q3 2023 Nov 03, 2023	BUY	$36.46 - $44.03 $7,802 - $9,422	214 Added 1.84%	11,871 $453,000
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $35,245 - $45,093	1,164 Added 11.09%	11,657 $420,000
Q1 2023 May 08, 2023	SELL	$32.86 - $55.7 $17,744 - $30,078	-540 Reduced 4.89%	10,493 $400,000
Q4 2022 Jan 25, 2023	SELL	$40.06 - $59.44 $13,380 - $19,852	-334 Reduced 2.94%	11,033 $0
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $139,709 - $187,754	3,626 Added 46.84%	11,367 $449,000
Q2 2022 Aug 10, 2022	BUY	$37.35 - $48.3 $289,126 - $373,890	7,741 New	7,741 $341,000
Q1 2019 Apr 09, 2019	SELL	$13.94 - $17.58 $3,624 - $4,570	-260 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$13.33 - $18.66 $3,465 - $4,851	260 New	260 $3,000
Q3 2018 Oct 09, 2018	SELL	$16.68 - $18.41 $4,336 - $4,786	-260 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$16.75 - $20.8 $4,355 - $5,408	260	260 $5,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.54B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account